Search
for

    Sort by

    Research 181–210 of 1000+

    1. Revisiting Rosacea Through the Skin–Gut–Brain Axis: A Neuroimmune Perspective Life · 2026
    2. Global trends in platelet-rich plasma research: A bibliometric review with hotspot visualization Medicine · 2026
    3. A Potential Differentiation of Adipose and Hair Follicle-derived Mesenchymal Stem Cells to Generate Neurons Induced with EGF, FGF, PDGF and Forskolin Research Journal of Pharmacy and Technology · 2020 · 14 citations
    4. LB1017 A novel link between human hair follicle neuroimmunology and mitochondrial biology: Substance P increases intrafollicular oxidative stress and mitochondrial biogenesis Journal of Investigative Dermatology · 2022
    5. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex) British Journal of Ophthalmology · 2002 · 21 citations
    6. Multiple iridociliary cysts in patients with mucopolysaccharidoses British Journal of Ophthalmology · 2002 · 21 citations
    7. Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations EClinicalMedicine · 2023 · 15 citations
    8. Bilateral non-specific orbital inflammation (orbital "pseudotumour"), posterior scleritis, and anterior uveitis associated with hypothyroidism in a child British Journal of Ophthalmology · 2002 · 15 citations
    9. Acquired ocular toxoplasmosis in pregnancy British Journal of Ophthalmology · 2002 · 10 citations
    10. Bilateral anterior uveitis as a presenting manifestation of sarcoidosis and syphilis British Journal of Ophthalmology · 2002 · 4 citations
    11. Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients 2022 · 2 citations
    12. Oral Signs of Hematologic Disease Springer eBooks · 2019 · 2 citations
    13. Tangent screens are still useful in the assessment of vigabatrin induced visual field defects British Journal of Ophthalmology · 2002 · 2 citations
    14. Clinical perspective on management of key adverse events with sacituzumab govitecan The Oncologist · 2025 · 1 citations
    15. Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer 2026
    16. A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer Cancer Research Communications · 2026
    17. Oculoplastic Surgery Atlas. Eyelid Disorders: . Eds Geoffrey J Gladstone, Evan H Black, Shoib Myint, Brian G Brazzo. Pp 130; pound66.50. Heidelberg: Springer-Verlag, 2001. ISBN 0-387-95316-7. British journal of ophthalmology · 2002
    18. An enzyme-linked immunosorbent assay for detection of botulinum toxin antibodies Toxicon · 2013
    19. Treatment of invasive aspergillosis with itraconazole The American Journal of Medicine · 1989 · 350 citations
    20. Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer ESMO Open · 2022 · 60 citations
    21. Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management Oncologist · 2013 · 24 citations
    22. Clinical Development of Topoisomerase-Interactive Drugs Advances in pharmacology · 1994 · 10 citations
    23. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
    24. Sacituzumab Govitecan-Hziy (Trodelvy™) Oncology Times · 2021 · 3 citations
    25. Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare 2023 · 1 citations
    26. Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies Refubium (Universitätsbibliothek der Freien Universität Berlin) · 2016
    27. Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI) European Journal of Cancer · 2010 · 93 citations
    28. Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®) European journal of oncology nursing · 2004 · 35 citations
    29. Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy JNCI Cancer Spectrum · 2019 · 26 citations
    30. Role of liposomal anthracyclines in the treatment of multiple myeloma Seminars in oncology · 2004 · 23 citations